EAPA Litigation

Under the Enforce and Protect Act, CBP investigates whether a company is evading particular antidumping and countervailing duty orders. Litigation on determinations made under the relatively new statute have centered on due process protections for respondents, CBP's evidentiary basis for its decisions and the interplay of decisions made on the scope of the applicable AD/CVD orders from both CBP and the Commerce Department. The Court of Appeals for the Federal Circuit issued a key decision for all EAPA cases in Royal Brush Manufacturing v. United States, when it found CBP to have violated a respondent's due process protections by failing to provide it with access to the business proprietary information used in the proceeding.

Date Range:

Author:

Topic:

Refine Category Search

Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "China import").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD antidumping).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +releases).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., -ruling).

Singular form: Use the singular form when doing multi-word terms (e.g. "russian export control" instead of "russian export controls").

Shortest word form: When you have different word forms in a quoted term, include the shortest version if it is the last part of the expression (e.g., "entity list" instead of "entity listing" or "entity listed").

New and Revised FDA Import Alerts for Feb. 28

March 3, 2014 by Brian Feito|FDA

On Feb. 28 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

New and Revised FDA Import Alerts for Feb. 27

February 28, 2014 by Brian Feito|FDA

On Feb. 27 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA Enforcement Report on Recalls & Field Corrections for Feb. 26

February 28, 2014 by Brian Feito|FDA

The Food and Drug Administration issued its weekly Enforcement Report for Feb. 26 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.

New and Revised FDA Import Alerts for Feb. 25

February 26, 2014 by Brian Feito|FDA

On Feb. 25 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

New and Revised FDA Import Alerts for Feb. 24

February 25, 2014 by Brian Feito|FDA

On Feb. 24 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

Other Modified FDA Import Alerts for the Week of Feb. 17-23

February 25, 2014 by Brian Feito|FDA

During the week of Feb. 17-23, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:

New and Revised FDA Import Alerts for Feb. 18-21

February 24, 2014 by Brian Feito|FDA

On Feb. 18-21 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA Enforcement Report on Recalls & Field Corrections for Feb. 19

February 21, 2014 by Brian Feito|FDA

The Food and Drug Administration issued its weekly Enforcement Report for Feb. 19 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.

FDA Announces New Food and Drug Safety Efforts in India

February 21, 2014 by Brian Feito|FDA

The Food and Drug Administration announced several new initiatives during Commissioner Margaret Hamburg’s recent trip to India, in a bid to build capacity and boost food and drug safety in the country. FDA is in the process of expanding its offices in India to include new staff, said an agency spokesman. During the trip, Hamburg also signed an agreement to work more closely with Indian food and drug regulators.

Lawsuit on Deadlines for FSMA Regs Ends as FDA Agrees to Timetable

February 21, 2014 by Brian Feito|FDA

The Food and Drug Administration reached a settlement with the Center for Food Safety on deadlines for its Food Safety Modernization Act regulations, ending a contentious lawsuit in the U.S. Court of Appeals for the 9th Circuit. The agency had been operating under deadlines ordered by the Northern California U.S. District Court in 2013 that required all seven of FDA’s final rules implementing FSMA by June 30, 2015 (see 13062412). The agreement extends the deadlines, some by nearly a year, in return for FDA dropping its appeal.